Feasibility of optical genome mapping in cytogenetic diagnostics of hematological neoplasms: a new way to look at DNA

N Coccaro, L Anelli, A Zagaria, F Tarantini, C Cumbo… - Diagnostics, 2023 - mdpi.com
Optical genome mapping (OGM) is a new genome-wide technology that can reveal both
structural genomic variations (SVs) and copy number variations (CNVs) in a single assay …

Autophagy in hematological malignancies

O García Ruiz, JM Sánchez-Maldonado… - Cancers, 2022 - mdpi.com
Simple Summary Autophagy is a dynamic and tightly regulated process that seems to have
dual effects in cancer. In some contexts, it can induce carcinogenesis and promote cancer …

[HTML][HTML] Contribution of histone variants to aneuploidy: a cancer perspective

D Ragusa, P Vagnarelli - Frontiers in Genetics, 2023 - frontiersin.org
Histone variants, which generally differ in few amino acid residues, can replace core
histones (H1, H2A, H2B, and H3) to confer specific structural and functional features to …

Dissecting the tumor microenvironment in response to immune checkpoint inhibitors via single-cell and spatial transcriptomics

W Liu, A Puri, D Fu, L Chen, C Wang, M Kellis… - Clinical & Experimental …, 2023 - Springer
Cancer is a disease that undergoes selective pressure to evolve during its progression,
becoming increasingly heterogeneous. Tumoral heterogeneity can dictate therapeutic …

Road testing new CAR design strategies in multiple myeloma

PS Rana, EV Murphy, J Kort, JJ Driscoll - Frontiers in Immunology, 2022 - frontiersin.org
A deeper understanding of basic immunology principles and advances in bioengineering
have accelerated the mass production of genetically-reprogrammed T-cells as living drugs …

Multiple myeloma: bioinformatic analysis for identification of key genes and pathways

C Saadoune, B Nouadi, H Hamdaoui… - … and Biology Insights, 2022 - journals.sagepub.com
Multiple myeloma (MM) is a hematological malignancy in which monoclonal plasma cells
multiply in the bone marrow and monoclonal immunoglobulins are overproduced in older …

Telomere length and hTERT genetic variants as potential prognostic markers in multiple myeloma

M Dratwa, P Łacina, A Butrym, D Porzuczek… - Scientific Reports, 2023 - nature.com
Telomere dysfunction is a notable event observed in many cancers contributing to their
genomic instability. A major factor controlling telomere stability is the human telomerase …

Newly Synthesized Melphalan Analogs Induce DNA Damage and Mitotic Catastrophe in Hematological Malignant Cancer Cells

A Poczta, P Krzeczyński, M Ionov, A Rogalska… - International Journal of …, 2022 - mdpi.com
Myeloablative therapy with highdoses of the cytostatic drug melphalan (MEL) in preparation
for hematopoietic cell transplantation is the standard of care for multiple myeloma (MM) …

G-Quadruplex Forming DNA Sequence Context Is Enriched around Points of Somatic Mutations in a Subset of Multiple Myeloma Patients

AS Zhuk, EI Stepchenkova, IV Zotova… - International journal of …, 2024 - mdpi.com
Simple Summary Genomic instability is an important feature of cancer, including multiple
myeloma, which is the second most common hematological malignancy. There are several …

The Interplay between the DNA Damage Response (DDR) Network and the Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway in Multiple Myeloma

P Malamos, C Papanikolaou, M Gavriatopoulou… - International Journal of …, 2024 - mdpi.com
The DNA damage response (DDR) network and the mitogen-activated protein kinase
(MAPK) signaling pathway are crucial mechanisms for the survival of all living beings. An …